Tristel
TSNLF (OTC)
Dividend yield
3.14%
Distribution
Semi-Annual
1-Year Return
8.51%
5-Year Return
399.13%
Tristel (LSE:TSTL) is a top-rated UK healthcare small cap specializing in infection prevention products for hospitals and clinics. With a robust 1-year return of 8.51% and an impressive 5-year return of 399.13%, the company also offers a dividend yield of 3.14%, making it an attractive option for investors seeking reliable income alongside growth potential.
Pros:
- High 5-year return
- Strong focus on infection control
Cons:
- Lower 1-year return compared to 5-year
- OTC market volatility risk
Tristel (TSNLF) may be suitable for investors looking for a combination of income and capital appreciation, particularly those interested in the healthcare sector and small-cap growth opportunities. With a solid track record of returns and a consistent dividend yield, it presents a compelling option for both income-focused and growth-oriented investors.